Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Acute Crit Care > Volume 41(3); 2026 > Article
Original Article
Pediatrics
Vasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
Acute and Critical Care 2026;41(3):654-660.
DOI: https://doi.org/10.4266/acc.008840
Published online: August 19, 2026

1Department of Pediatrics, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea

2Department of Radiology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea

3Department of Thoracic and Cardiovascular Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea

4Department of Thoracic and Cardiovascular Surgery, Korea University Anam Hospital, Korea University School of Medicine, Seoul, Korea

Corresponding author: Kwang Ho Choi Department of Thoracic and Cardiovascular Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea Tel: +82-55-360-2127, Fax: +82-55-360-2157, Email: ppippo77@gmail.com
• Received: September 16, 2025   • Revised: April 8, 2026   • Accepted: April 13, 2026

© 2026 The Korean Society of Critical Care Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,056 Views
  • 25 Download
prev next
  • Background
    Venovenous (VV) extracorporeal membrane oxygenation (ECMO) supports pediatric patients with severe respiratory failure; however, some experience clinical deterioration requiring conversion to venoarterial (VA) ECMO or resulting in mortality. The prognostic role of the vasoactive-inotropic score (VIS) at VV ECMO cannulation remains unclear.
  • Methods
    We retrospectively analyzed pediatric patients who underwent VV ECMO between 2010 and 2024 at a single center. Baseline VIS was calculated from vasoactive infusion rates documented immediately prior to cannulation. The primary composite outcome was conversion to VA ECMO or in-hospital mortality. Associations between VIS and outcomes were assessed using correlation, univariable logistic regression, and receiver operating characteristic (ROC) analysis.
  • Results
    Twenty patients underwent VV ECMO. Five (25.0%) required VA conversion, seven (35.0%) died, and nine (45.0%) met the composite outcome. Baseline VIS was not significantly associated with isolated mode change (r=0.13, P=0.589) and showed a borderline association with mortality (r=0.43, P=0.062). Logistic regression demonstrated a consistent direction of association between higher baseline VIS and the composite outcome (odds ratio, 1.04; 95% CI, 1.00–1.09; P=0.078). Correlation analysis also suggested an association (r=0.54, P=0.014). ROC analysis demonstrated an area under the curve of 0.79, suggesting potential discriminative ability, with an exploratory cutoff of 25.
  • Conclusions
    Baseline VIS showed a possible association with clinical deterioration in this pilot cohort. These findings are exploratory and require validation in larger prospective multicenter studies.
Venovenous extracorporeal membrane oxygenation (VV ECMO) has become an important rescue therapy for respiratory failure in pediatrics. According to the Extracorporeal Life Support Organization guidelines, VV ECMO is preferred for isolated respiratory failure when cardiac function is preserved, providing oxygenation and ventilation support while allowing lung recovery [1]. Compared with venoarterial (VA) ECMO, VV ECMO is generally preferred when cardiac function is preserved, owing to the lower risk of complications related to arterial cannulation, systemic embolization, and preservation of native cardiac output [2]. However, determining the optimal ECMO mode in critically ill pediatric patients can be challenging, particularly in the presence of hemodynamic instability at initiation. Early recognition of circulatory deterioration during VV ECMO is important, as delayed transition to VA ECMO may be associated with worse outcomes.
The vasoactive-inotropic score (VIS) is an established surrogate marker of cardiovascular support intensity and hemodynamic compromise. Initially developed by Gaies et al. [3] to quantify pharmacologic circulatory support after pediatric cardiothoracic surgery, the VIS has since been validated as a prognostic indicator across various pediatric critical care populations, including postcardiac surgery patients [4], septic shock [5], and those requiring ECMO support [6-8]. Elevated VIS values have been associated with increased mortality and adverse outcomes, and thresholds exceeding 42–60 have been reported as markers of high risk in both cardiac and respiratory ECMO cohorts [6,7]. A recent systematic review further reinforced the predictive utility of VIS across surgical and critical care settings [7].
However, prior studies have primarily evaluated VIS trajectories over the first 24–48 hours of ECMO support rather than VIS at the initiation of cannulation. While dynamic VIS trends provide valuable information, such measurements may not be available during emergent VV ECMO initiation, when time-sensitive decisions regarding ECMO mode must be made. Whether a single baseline VIS at cannulation can identify children at risk of circulatory deterioration, defined as conversion to VA ECMO or mortality, remains unclear and represents an important gap in the current literature.
Early identification of such patients may help refine candidate selection and guide the intensity of hemodynamic monitoring. Therefore, this study aimed to evaluate whether VIS at the time of VV ECMO initiation predicts subsequent clinical deterioration in pediatric patients with respiratory failure. We hypothesized that higher VIS values at cannulation would reflect early circulatory vulnerability and be associated with increased risk of adverse outcomes during VV ECMO support.
Study Design and Setting
The study was approved by the Institutional Review Board of Pusan National University Yangsan Hospital (No. 55-2025-056), and the requirement for informed consent was waived due to the retrospective design. This retrospective cohort study included pediatric patients who underwent VV ECMO for respiratory failure at our center between January 2010 and December 2024.
Patient Selection
Children younger than 18 years who were initiated on VV ECMO for acute respiratory failure were screened for eligibility. Patients were excluded if ECMO was initiated in VA mode, including cases subsequently converted from VA to VV ECMO, or if they had uncorrected congenital heart disease, had undergone total pneumonectomy, or had incomplete medical records that precluded accurate VIS calculation or outcome assessment. After applying these criteria, 20 patients remained in the final analytic cohort (Figure 1).
Data Collection
Demographic, clinical, and hemodynamic data at the time of ECMO cannulation were collected from electronic medical records. The VIS was calculated from vasoactive infusion rates documented in the medical record prior to cannulation according to the formula originally described by Gaies et al. [3]:
VIS=dopamine (μg/kg/min)+dobutamine (μg/kg/min)+100×epinephrine (μg/kg/min)+10×milrinone (μg/kg/min)+10,000×vasopressin (U/kg/min)+100×norepinephrine (μg/kg/min)
Serial VIS values at 24 and 48 hours after cannulation were additionally collected for exploratory analysis. Cannulation configuration was categorized as right internal jugular double-lumen, other peripheral (femoral–internal jugular or femoral–femoral), or initial central VV ECMO. During the revision process, all clinical outcomes were re-verified through detailed chart review, and minor corrections to event classification were made to ensure data accuracy. No changes were made to inclusion criteria or predefined outcome definitions.
Outcomes
The primary outcome was a composite clinical deterioration endpoint, defined as conversion from VV to VA ECMO or mortality. Conversion to VA ECMO was performed at the discretion of the attending intensivist in cases of persistent hemodynamic instability, inadequate systemic perfusion, or evolving cardiac dysfunction on echocardiography. Secondary outcomes included the individual components of the composite endpoint: VA conversion and mortality. Patients who underwent lung transplantation while on VV ECMO and were subsequently weaned were not classified as composite events unless VA conversion or mortality occurred.
Statistical Analyses
Continuous variables were summarized as medians with interquartile ranges (IQRs) and compared using the Mann-Whitney U-test. Categorical variables were compared using Fisher’s exact test. Associations between VIS and clinical outcomes (VA conversion, mortality, and the composite event) were evaluated using point-biserial correlation and univariable logistic regression. Because of the limited number of events and the associated risk of model overfitting, multivariable regression was not performed.
The discriminative ability of VIS for predicting the composite event was assessed using receiver operating characteristic (ROC) curve analysis, and the optimal cutoff value was determined using the Youden index. Statistical significance was defined as P<0.05. All analyses were performed using IBM SPSS version 26.0 (IBM Corp.) and Python 3.10 for supplementary analyses.
Twenty pediatric patients underwent VV ECMO during the study period. The median age at cannulation was 13.9 months (IQR, 7.3–85.4), and the median VIS at cannulation was 15.0 (IQR, 4.5–55.0). Five patients (25.0%) required conversion to VA ECMO, seven (35.0%) died before hospital discharge, and nine (45.0%) experienced the composite event. One patient underwent lung transplantation while on VV ECMO and was subsequently weaned; this case was not classified as a composite event because neither VA conversion nor mortality occurred. Baseline characteristics are summarized in Table 1.
VIS at cannulation was not significantly associated with isolated mode change (r=0.13, P=0.589). A borderline association was observed with mortality (r=0.43, P=0.062). Univariable logistic regression yielded similar findings, with no significant association between VIS and mode change (odds ratio [OR], 1.01; 95% CI, 0.99–1.03; P=0.570) or mortality (OR, 1.02; 95% CI, 1.00–1.04; P=0.091). Patients who experienced composite outcome had higher VIS values at cannulation than those who did not (r=0.54, P=0.014). Logistic regression showed a consistent direction of association between higher baseline VIS and increased risk of the composite outcome (OR, 1.04; 95% CI, 1.00–1.09; P=0.078).
ROC analysis demonstrated discriminative performance of VIS for predicting the composite event, with an area under the curve of 0.79. The optimal cutoff determined by the Youden index was 25, yielding a sensitivity of 66.7% and a specificity of 81.8% (Figure 2).
Exploratory analysis of serial VIS values showed higher VIS at both 24 and 48 hours in patients who experienced the composite outcome compared to those without events (Supplementary Table 1). When patients were stratified by this cutoff, the high VIS group (VIS ≥25) was significantly younger (median, 8.8 vs. 74.9 months; P=0.031) and had a smaller body surface area (0.37 vs. 0.86 m², P=0.011). Although not statistically significant, the high VIS group exhibited higher rates of mode change (37.5% vs. 16.7%, P=0.347) and mortality (62.5% vs. 16.7%, P=0.062). Composite events were also more common in the high VIS group (75.0% vs. 25.0%, P=0.065). These comparisons are summarized in Table 2.
Cannulation configuration included right internal jugular double-lumen (n=10), other peripheral approaches (femoral-internal jugular or femoral-femoral; n=6), and initial central VV ECMO (n=4). The distribution of cannulation approaches was not significantly associated with the composite outcome (P=0.203). In addition, no procedure-related complications directly leading to VA conversion or mortality were identified in this cohort.
In this pediatric VV ECMO cohort, a higher VIS measured at the time of cannulation showed a consistent direction of association with the composite outcome in regression analysis, although the association did not reach statistical significance. Accordingly, these findings should be interpreted cautiously and regarded as exploratory rather than confirmatory.
The discrepancy between individual outcomes and the composite endpoint likely reflects limited statistical power in this small pilot cohort. With only nine composite events, the study was underpowered to detect modest associations, and nonsignificant findings may represent type II error rather than the absence of a true relationship. Although the direction of effect was generally consistent across analyses, the wide confidence intervals indicate uncertainty in effect estimation.
Our findings are broadly consistent with previous work evaluating the prognostic utility of VIS in pediatric critical illness. Elevated VIS has been associated with worse outcomes after cardiothoracic surgery [3,4] and in pediatric septic shock and sepsis [5,6]. In ECMO populations, higher pre-ECMO or on-ECMO VIS has been linked to increased morbidity and mortality [7,8]. A recent systematic review in surgical patients further confirmed a strong association between high VIS values and adverse outcomes [9]. Taken together, these studies support the physiological relevance of VIS as a marker of pharmacologic circulatory support and hemodynamic compromise, although the magnitude of association in the present study remains uncertain.
Dynamic changes in VIS also appear important. Sewell et al. [10] reported that decreases in VIS over the first 24 hours after ECMO initiation were more predictive of survival than baseline values alone. Similarly, Chilcote et al. [11] demonstrated that VV ECMO initiation for pediatric acute respiratory distress syndrome with cardiovascular instability led to an immediate and sustained reduction in VIS, suggesting that VV ECMO can stabilize hemodynamics even in patients with significant pre-ECMO vasoactive requirements.
In the present study, exploratory analyses showed higher VIS values at 24 and 48 hours in patients who experienced the composite outcome (Supplementary Table 1); however, early events and missing data limited formal trajectory modeling. Therefore, the primary focus remained on baseline VIS at cannulation, which may offer clinically relevant information at the time of initial ECMO mode selection.
Mode choice itself has important prognostic implications. A registry-based analysis by Furlong-Dillard et al. showed that, among pediatric patients eligible for both modes, those supported with VV ECMO had higher survival than those supported with VA ECMO [12]. These findings support the preferential use of VV ECMO when feasible, while underscoring the need for robust risk stratification tools to identify patients at risk for circulatory deterioration during VV support. Kim et al. [13] also reported the feasibility of percutaneous bicaval dual-lumen cannulation for pediatric respiratory extracorporeal life support using a single internal jugular venous approach. Although that study focused primarily on the technical aspects of cannulation, it further highlighted the expanding role of VV ECMO in pediatric respiratory failure and emphasized the importance of appropriate patient selection and timely recognition of hemodynamic deterioration. Recent reviews have highlighted the broader clinical utility of VIS as a standardized metric that can facilitate communication, triage decisions, and comparisons across centers [14]. In this framework, VIS at cannulation may represent one objective parameter that complements clinical assessment rather than serving as a standalone determinant of ECMO mode selection. Cannulation configuration was not significantly associated with the composite outcome, and no procedure-related complications directly leading to VA conversion or mortality were identified. These findings suggest that the observed associations were unlikely to be driven by technical factors.
In our cohort, patients in the higher VIS group were significantly younger and had smaller body surface areas than those with lower VIS. These findings suggest that younger and smaller children may be particularly vulnerable during VV ECMO; however, it remains uncertain whether the observed deterioration reflects VIS itself or underlying physiologic vulnerability associated with younger age and smaller body size. These findings are consistent with established pediatric physiologic data showing higher metabolic demand, limited cardiovascular reserve, and increased susceptibility to hemodynamic instability in younger children [15,16].
This study has several limitations. First, the retrospective single-center study design and small sample size limit the generalizability of the findings. With only nine composite events, the study was underpowered to detect modest associations, and wide confidence intervals observed in regression analyses indicate substantial statistical uncertainty. Second, although serial VIS values were collected for exploratory analysis, early events and missing data limited formal trajectory modeling of VIS changes after ECMO initiation. Third, key physiological variables such as lactate levels and ventilator parameters were not consistently available at the exact time of cannulation. Several patients were cannulated by our ECMO team at referring hospitals and subsequently transferred, making it difficult to retrospectively obtain ventilator parameters at a standardized time point immediately before cannulation. Consequently, including only selectively available values could have introduced additional bias. In addition, unmeasured differences in institutional practices, evolving ECMO protocols, and provider experience may also have contributed to the findings.
Despite these limitations, this study provides hypothesis-generating evidence that VIS measured at VV ECMO cannulation may reflect early circulatory vulnerability in pediatric patients. VIS may represent one component of a broader clinical assessment and could assist, but not replace, clinical judgment in ECMO mode selection. Accordingly, larger prospective multicenter studies are needed to validate these observations and to clarify how baseline and serial VIS measurements may be integrated into risk stratification and ECMO mode selection.
▪ Baseline vasoactive-inotropic score (VIS) at the time of venovenous extracorporeal membrane oxygenation cannulation may reflect early circulatory vulnerability and was associated with adverse clinical outcomes, defined as venoarterial (VA) conversion or mortality, in exploratory analyses.
▪ VIS demonstrated moderate discriminative ability for predicting a composite endpoint of VA conversion or mortality, with an exploratory cutoff of 25 showing clinically meaningful sensitivity and specificity.
▪ Although limited by small sample size, these findings suggest that baseline VIS may represent a potential adjunct for early risk stratification during extracorporeal membrane oxygenation mode selection, warranting validation in large multicenter studies.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

None.

ACKNOWLEDGMENTS

None.

AUTHOR CONTRIBUTIONS

Conceptualization: KHC. Data curation: KHC, JHL, JHB. Formal analysis: KHC, JHB. Methodology: KHC, JHB, HK. Project administration: KHC, YAK. Visualization: KHC, JHB. Writing - original draft: KHC, JHB. Writing - review & editing: JHB, YAK, HJB, HK, JHL, KHC. All authors read and agreed to the published version of the manuscript.

Supplementary materials can be found via https://doi.org/10.4266/acc.008840.
Supplementary Table 1.
Serial VIS values 24 and 48 hours after VV ECMO cannulation according to composite outcome
acc-008840-Supplementary-Table-1.pdf
Figure 1.
Flowchart of patient selection for this study. ECMO: extracorporeal membrane oxygenation; VA: venoarterial; CHD: congenital heart disease; VV: venovenous.
acc-008840f1.jpg
Figure 2.
Receiver operating characteristic curve for vasoactive-inotropic score at venovenous extracorporeal membrane oxygenation cannulation to predict composite clinical deterioration (conversion to venoarterial extracorporeal membrane oxygenation or mortality). The area under the curve (AUC) was 0.79 (95% CI, 0.61–0.99). A cutoff value of 25.0 yielded 66.7% sensitivity and 81.8% specificity.
acc-008840f2.jpg
Table 1.
Patient characteristics
Variable Value
Number of patients 20
Age at ECMO initiation (mo) 13.9 (7.3−85.4)
VIS at ECMO initiation 15.0 (4.5−55.0)
Mode change to VA ECMO 5 (25.0)
Mortality 7 (35.0)
Composite eventa) 9 (45.0)

Values are presented as median (interquartile range) or number (%).

ECMO: extracorporeal membrane oxygenation; VIS: vasoactive-inotropic score; VA ECMO: venoarterial extracorporeal membrane oxygenation.

a)Composite event: mode change to VA ECMO or mortality.

Table 2.
Comparison of low versus high VIS groups
Variable Low VIS (<25.0, n=12) High VIS (≥25.0, n=8) P-value
Age (mo) 74.9 (11.3−145.2) 8.8 (4.2−13.6) 0.031
BSA (m²) 0.86 (0.4−1.3) 0.37 (0.3−0.4) 0.011
Mode change to VA ECMO 2 (16.7) 3 (37.5) 0.347
Mortality 2 (16.7) 5 (62.5) 0.062
Composite eventa) 3 (25.0) 6 (75.0) 0.065

Values are presented as median (interquartile range) or number (%).

VIS: vasoactive-inotropic score; BSA: body surface area; VA ECMO: venoarterial extracorporeal membrane oxygenation.

a)Composite event: mode change to VA ECMO or mortality.

  • 1. Maratta C, Potera RM, van Leeuwen G, Castillo Moya A, Raman L, Annich GM, et al. Extracorporeal life support organization (ELSO): 2020 pediatric respiratory ELSO guideline. ASAIO J 2020;66:975-9.ArticlePubMed
  • 2. Paden ML, Rycus PT, Thiagarajan RR; ELSO Registry. Update and outcomes in extracorporeal life support. Semin Perinatol 2014;38:65-70.ArticlePubMed
  • 3. Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010;11:234-8.ArticlePubMed
  • 4. Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J, et al. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants after cardiothoracic surgery. Intensive Care Med 2012;38:1184-90.ArticlePubMedPMCPDF
  • 5. McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med 2017;18:750-7.ArticlePubMedPMC
  • 6. Kallekkattu D, Rameshkumar R, Chidambaram M, Krishnamurthy K, Selvan T, Mahadevan S, et al. Threshold of inotropic score and vasoactive-inotropic score for predicting mortality in pediatric septic shock. Indian J Pediatr 2022;89:432-7.ArticlePubMedPMCPDF
  • 7. Sandrio S, Krebs J, Leonardy E, Thiel M, Schoettler JJ. Vasoactive inotropic score as a prognostic factor during (cardio-) respiratory ECMO. J Clin Med 2022;11:2390.ArticlePubMedPMC
  • 8. Shukla I, Hanson SJ, Yan K, Zhang J. Vasoactive-inotropic score and vasoactive-ventilation-renal score as outcome predictors for children on extracorporeal membrane oxygenation. Front Pediatr 2021;9:769932.ArticlePubMedPMC
  • 9. Sun YT, Wu W, Yao YT. The association of vasoactive-inotropic score and surgical patients' outcomes: a systematic review and meta-analysis. Syst Rev 2024;13:20.ArticlePubMedPMCPDF
  • 10. Sewell EK, Piazza AJ, Davis J, Heard ML, Figueroa J, Keene SD, et al. Inotrope needs in neonates requiring extracorporeal membrane oxygenation for respiratory failure. J Pediatr 2019;214:128-33.ArticlePubMed
  • 11. Chilcote D, Sriram A, Slovis J, Morgan RW, Schaubel DE, Connelly J, et al. Venovenous extracorporeal membrane oxygenation initiation for pediatric acute respiratory distress syndrome with cardiovascular instability is associated with an immediate and sustained decrease in vasoactive-inotropic scores. Pediatr Crit Care Med 2024;25:e41-6.ArticlePubMed
  • 12. Furlong-Dillard JM, Feygin YB, Reeder RW, Wilson JS, Blauvelt DG, Todd-Tzanetos DR, et al. Comparing outcomes of venovenous versus venoarterial extracorporeal membrane oxygenation in neonatal and pediatric respiratory failure: a retrospective review of Extracorporeal Life Support Organization registry. J Pediatr Crit Care 2023;10:205-12.ArticlePubMed
  • 13. Kim W, Kwon HW, Min J, Cho S, Kwak JS, Park JD, et al. Percutaneous bicaval dual lumen cannula for extracorporeal life support. Acute Crit Care 2020;35:207-12.ArticlePubMedPMCPDF
  • 14. Belletti A, Lerose CC, Zangrillo A, Landoni G. Vasoactive-inotropic score: evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth 2021;35:3067-77.ArticlePubMed
  • 15. Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet 2011;377:1011-8.ArticlePubMedPMC
  • 16. de Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, et al. Part 12: pediatric advanced life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015;132:S526-42.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite
        CITE
        export Copy
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Vasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
        Acute Crit Care. 2026;41(3):654-660.   Published online August 19, 2026
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      Related articles
      Vasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
      Image Image
      Figure 1. Flowchart of patient selection for this study. ECMO: extracorporeal membrane oxygenation; VA: venoarterial; CHD: congenital heart disease; VV: venovenous.
      Figure 2. Receiver operating characteristic curve for vasoactive-inotropic score at venovenous extracorporeal membrane oxygenation cannulation to predict composite clinical deterioration (conversion to venoarterial extracorporeal membrane oxygenation or mortality). The area under the curve (AUC) was 0.79 (95% CI, 0.61–0.99). A cutoff value of 25.0 yielded 66.7% sensitivity and 81.8% specificity.
      Vasoactive-inotropic score as a predictor of clinical deterioration in pediatric patients undergoing venovenous extracorporeal membrane oxygenation: a preliminary single-center study in South Korea
      Variable Value
      Number of patients 20
      Age at ECMO initiation (mo) 13.9 (7.3−85.4)
      VIS at ECMO initiation 15.0 (4.5−55.0)
      Mode change to VA ECMO 5 (25.0)
      Mortality 7 (35.0)
      Composite eventa) 9 (45.0)
      Variable Low VIS (<25.0, n=12) High VIS (≥25.0, n=8) P-value
      Age (mo) 74.9 (11.3−145.2) 8.8 (4.2−13.6) 0.031
      BSA (m²) 0.86 (0.4−1.3) 0.37 (0.3−0.4) 0.011
      Mode change to VA ECMO 2 (16.7) 3 (37.5) 0.347
      Mortality 2 (16.7) 5 (62.5) 0.062
      Composite eventa) 3 (25.0) 6 (75.0) 0.065
      Table 1. Patient characteristics

      Values are presented as median (interquartile range) or number (%).

      ECMO: extracorporeal membrane oxygenation; VIS: vasoactive-inotropic score; VA ECMO: venoarterial extracorporeal membrane oxygenation.

      Composite event: mode change to VA ECMO or mortality.

      Table 2. Comparison of low versus high VIS groups

      Values are presented as median (interquartile range) or number (%).

      VIS: vasoactive-inotropic score; BSA: body surface area; VA ECMO: venoarterial extracorporeal membrane oxygenation.

      Composite event: mode change to VA ECMO or mortality.


      ACC : Acute and Critical Care
      TOP